(19)
(11) EP 4 565 599 A1

(12)

(43) Date of publication:
11.06.2025 Bulletin 2025/24

(21) Application number: 23850538.2

(22) Date of filing: 04.08.2023
(51) International Patent Classification (IPC): 
C07K 14/395(2006.01)
A61P 9/00(2006.01)
 A61K 38/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/00; C07K 14/395; A61K 38/00; G01N 2500/00
(86) International application number:
PCT/SG2023/050540
(87) International publication number:
WO 2024/030080 (08.02.2024 Gazette 2024/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.08.2022 SG 10202250671T

(71) Applicant: Nanyang Technological University
Singapore 639798 (SG)

(72) Inventors:
  • MIAO, Yansong
    Singapore 639798 (SG)
  • MA, Qianqian
    Singapore 639798 (SG)
  • HE, Danxia
    Singapore 639798 (SG)
  • NG, Cai Xin
    Singapore 639798 (SG)

(74) Representative: Marks & Clerk LLP 
15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)

   


(54) ADP-ACTIN-SPECIFIC PROTEIN AND MOTIFS TO REMODEL ACTIN CYTOSKELETON IN LIVING CELLS AND IN VITRO BIOCHEMISTRY